Hematopoietic cells normally require cell extrinsic signals to maintain metabolism and survival. In contrast, cancer cells can express constitutively active oncogenic kinases such as BCR-Abl that promote these processes independent of extrinsic growth factors. When cells receive insufficient growth signals or when oncogenic kinases are inhibited, glucose metabolism decreases and the self-digestive process of autophagy is elevated to degrade bulk cytoplasm and organelles. Although autophagy has been proposed to provide a cell-intrinsic nutrient supply for mitochondrial oxidative metabolism and to maintain cellular homeostasis through degradation of damaged organelles or protein aggregates, its acute role in growth factor deprivation or inhibition of oncogenic kinases remains poorly understood. We therefore developed a growth factor-dependent hematopoietic cell culture model in which autophagy can be acutely disrupted through conditional Cre-mediated excision of the autophagy-essential gene Atg3. Treated cells rapidly lost their ability to perform autophagy and underwent cell cycle arrest and apoptosis. Although Atg3 was essential for optimal upregulation of mitochondrial oxidative pathways in growth factor withdrawal, this metabolic contribution of autophagy did not appear critical for cell survival, as provision of exogenous pyruvate or lipids could not completely rescue Atg3 deficiency. Instead, autophagy suppressed a stress response that otherwise led to p53 phosphorylation and upregulation of p21 and the proapoptotic Bcl-2 family protein Puma. Importantly, BCRAbl-expressing cells had low basal levels of autophagy, but were highly dependent on this process, and rapidly underwent apoptosis upon disruption of autophagy through Atg3 deletion or treatment with chemical autophagy inhibitors. This dependence on autophagy extended in vivo, as Atg3 deletion also prevented BCR-Abl-mediated leukemogenesis in a cell transfer model. Together these data demonstrate a critical role for autophagy to mitigate cell stress, and that cells expressing the oncogenic kinase BCR-Abl appear particularly dependent on autophagy for cell survival and leukemogenesis.
Introduction
Normal metazoan cells require growth factors to sustain metabolism, maintain cellular homeostasis and prevent cell death (Raff, 1992; Rathmell et al., 2000) . In contrast, cancer cells can express oncogenic kinases to mimic growth factors and render cells independent of extrinsic signals (Hanahan and Weinberg, 2000; DeBerardinis et al., 2008) . Insufficient access to, or inhibition of, these signals can lead to cellular atrophy with decreased nutrient uptake and activation of the self-digestive process of autophagy Rathmell et al., 2000; Lum et al., 2005a; Wieman et al., 2007; Altman and Rathmell, 2009) . Autophagy likely has a key role in this stress response (Colell et al., 2007; Altman et al., 2009) , but the acute role of autophagy in cells deprived of growth signals and how inhibition of autophagy may influence targeted cancer therapies, however, remains largely uncertain.
Autophagy may influence cells deprived growth signals through several pathways. Autophagosomes may specifically target damaged mitochondria (Colell et al., 2007; Kim et al., 2007) , peroxisomes (Iwata et al., 2006) or protein aggregates (Pankiv et al., 2007) to maintain intracellular homeostasis of organelles and proteins. Indeed, protein aggregates can lead to DNA damage and genomic instability Mathew et al., 2009) , and accumulation of damaged mitochondria can promote apoptosis (Mathew et al., 2009) . Autophagy may also provide nutrients through lysosomal degradation of intracellular components for mitochondrial oxidation (Lum et al., 2005b; Mathew et al., 2007; Altman et al., 2009; Singh et al., 2009) . Under cases of prolonged growth-factor deprivation when apoptosis is suppressed, this metabolic contribution appears critical to sustain cell viability (Lum et al., 2005a) .
Given its potential function in metabolism and cell survival, manipulation of autophagy may provide a critical means to eliminate cancer cells. Heterozygosity for the autophagy-essential gene Beclin-1 led to greatly increased rates of tumorigenesis (Liang et al., 1999; Yue et al., 2003) , possibly because of genomic instability when autophagy was reduced . Conversely, autophagy has also been shown to promote survival of cancer cells following stress or nutrient deprivation (Lum et al., 2005a; Degenhardt et al., 2006; Karantza-Wadsworth et al., 2007) . A promising setting for inhibition of autophagy may be in treatment of cancers driven by oncogenic kinases that mimic growth signals, such as BCR-Abl, where inhibition of autophagy may enhance kinase inhibitor-induced apoptosis (Carew et al., 2007; Kamitsuji et al., 2008; Bellodi et al., 2009) . Nevertheless, the precise role for autophagy and how inhibition of this process may impact BCR-Abl þ leukemia is uncertain. To directly address the role of autophagy in control of cell metabolism and viability, we have generated a model for acute genetic inhibition of the autophagy pathway using conditional deletion of the autophagyessential gene Atg3. Cre-mediated Atg3 excision led to disruption of autophagy, cell cycle arrest and eventual apoptotic cell death, both in the presence and absence of growth factor. We observed specific metabolic contributions from autophagy, but these nutrients did not appear critical for cell survival. Rather, disruption of autophagy led to p53 pathway activation with cell cycle arrest, Puma induction, and apoptosis. Interestingly, cells expressing oncogenic BCR-Abl had low levels of basal autophagy, but were highly sensitive to autophagy disruption and failed to generate leukemia upon Atg3 deletion in vivo. Together, these data directly demonstrate that inhibition of autophagy can enhance cell stress to promote cell death and prevent BCR-Abldriven leukemogenesis.
Results

Generation of a hematopoietic cell model for conditional Atg3 deletion
We developed a model for conditional deletion of the autophagy-essential gene Atg3 to examine the role of autophagy. Hematopoietic precursor cells from Atg3 F/F Cre-ER (A3C) mice were isolated and infected with Hox11-expressing virus to suppress cell differentiation ( Figure 1a ) . This mixed population of hematopoietic progenitor cells could be expanded in IL3, and Atg3 was readily excised when treated with 4-hydroxytamoxifen (4OHT) to activate Cre recombinase ( Figure 1b ). 4OHT did not cause Atg3 loss (Supplementary Figure S1A) or cytotoxicity in cells lacking Cre-ER (Supplementary Figure S1B) , and activation of Cre by 4OHT in cells with wild-type Atg3 did not result in loss of viability or growth (Supplementary Figure S1C-D) . To ensure Cremediated DNA excision did not elicit a DNA damage response, bone marrow from control and IL7R F/F Cre-ER mice (Jacobs et al., 2010) was harvested and treated with either 4OHT to delete IL7R, a gene not expressed in hematopoietic precursor cells, or etoposide to directly cause DNA damage. gH2A.X, a marker of DNA double-strand breaks (Kurz and Lees-Miller, 2004) , was observed after etoposide treatment but not 4OHT treatment (Supplementary Figure S1E) .
To examine the role of autophagy in cell metabolism and apoptosis, A3C cells were transduced to stably overexpress the glucose transporter Glut1, the antiapoptotic protein Bcl-2 or a truncated and nonfunctional human nerve growth factor receptor marker as a control (Supplementary Figure S2A) . Cell surface Glut1 was observed by flow cytometric staining (Supplementary Figure S2B) . In each cell population, 4OHT treatment resulted in decreased Atg3 expression (Supplementary Figure  S2C) . Functionally, Atg3 deletion disrupted autophagy, as 4OHT treatment impaired accumulation of the autophagy markers and Atg3 targets LC3-II, GABARAP and Gate-16, and increased accumulation of p62, a protein normally degraded by autophagy (Bjorkoy et al., 2005) (Figure 1c ). As autophagy leads to lysosomal degradation of autophagosomes, and total levels of LC3-II, GABARAP, Gate-16 and p62 reflect both processing and degradation, cells were treated with chloroquine to block lysosomal proteolysis (Figure 1d ). In each case, Atg3 excision prevented protein processing. A3C cells were also analyzed in the presence or absence of 4OHT by high throughput image analysis to quantitate GFP-LC3 punctae (Figure 1e ). 4OHT-treated cells had fewer GFP-LC3 punctae, indicating that Atg3 deletion disrupted basal levels of autophagy. Together, these data show that 4OHT and Cre recombination are not intrinsically cytotoxic and that Atg3 can be efficiently excised in the A3C cell population leading to acute genetic blockade of autophagy.
Atg3 deletion leads to cell cycle arrest and enhanced death The establishment of A3C cells allowed direct examination of the role of autophagy on cell growth and survival. Atg3 was essential for cell accumulation over time in culture with IL3 ( Figure 2a ). This was due in part to cell cycle arrest, as expression of Bcl-2 to suppress apoptosis did not prevent cell cycle arrest, and Bcl-2-expressing A3C cells did not efficiently incorporate BrdU (Figure 2b ) and arrested in G1 or G2 of the cell cycle (Figure 2c ) after Atg3 deletion. Growth factor deprivation leads to atrophy and decreased cell metabolism through increased proteolysis and reduced nutrient uptake (Rathmell et al., 2000; Edinger and Thompson, 2002; Wieman et al., 2007) , and Atg3 deletion partially maintained cell size of apoptosisresistant Bcl-2-expressing A3C cells deprived IL3 (Figure 3a) . Importantly, deletion of Atg3 led to increased cell death in both the presence and absence of IL3, but this death was partially inhibited by expression of Bcl-2, which allowed extended survival in the absence of both Atg3 and IL3 (Figure 3b ). These data suggested a role for apoptosis and Bcl-2 family proteins in the death of IL3-deprived Atg3-deficient cells. Indeed, IL3 withdrawal led to loss of Mcl-1 and induction of the pro-apoptotic proteins Puma and Bim, and this was enhanced in Atg3-deficient cells (Figure 3c ). Further supporting apoptosis as the mechanism of cell death, deletion of Atg3 also resulted in accumulation of cells with activated Bax and sub-diploid DNA content (Supplementary Figure S3A- 
B).
Autophagy supports but does not appear essential for metabolism of acutely growth factor-deprived cells Pharmacologic inhibition or chronic genetic deletion experiments have shown that lipid oxidation of nutrients made available through autophagic degradation of intracellular components (Altman and Rathmell, 2009; Singh et al., 2009) can support the survival of metabolically stressed cells (Degenhardt et al., 2006; Altman et al., 2009) . Indeed, Atg3-deficient cells were more sensitive to cell death upon treatment with the glycolytic inhibitor 2-deoxyglucose than autophagycompetent cells (Supplementary Figure S4) .
Autophagy may also support cell metabolism upon decreased nutrient uptake following growth-factor deprivation (Lum et al., 2005a) . IL3 deprivation decreased glycolytic flux (Figure 4a ), demonstrating that growth factors mediate control of glycolytic metabolism in A3C cells. To directly establish the contribution of autophagy to cell metabolism in this isogenic system, we undertook mass spectrometry-based metabolomic analyses of A3C cells that were either treated or untreated with 4OHT to delete Atg3 and cultured in the presence or absence of IL3. Consistent with growth factor regulation of glycolytic rate, IL3 deprivation reduced levels of intracellular lactate and organic acids derived from glucose metabolism and the tri-carboyxlic acid cycle regardless of Atg3 status (Figure 4b and Supplementary Figure S5A ). Acylcarnitines, which are indicative of fuels available for mitochondrial oxidation and are derived from fatty acids that may be produced from the breakdown of membranes, were increased upon IL3 deprivation in an Atg3-dependent manner Altman et al., 2009) (Figure 4c ). Intracellular levels of some amino acids also increased in IL3-deprived cells that expressed Atg3 but not in Atg3-deficient cells (Supplementary Figure S5B-D) .
Provision of nutrients may mediate the survival benefits of autophagy in growth factor deprivation, and addition of exogenous nutrients may replace autophagy to support the viability of growth factordeprived cells. Control and Bcl-2-expressing cells were cultured in the presence or absence of 4OHT, withdrawn from IL3, and provided methyl-pyruvate, a cell permeable form of the end-glycolytic product pyruvate, a 1:1 mixture of the long-chain fatty acids oleate and palmitate, or a combination of these nutrients (Figures 4d and e) . No condition rescued Atg3-deficient cells from enhanced death after growth factor withdrawal. Neither methylpyruvate nor oleate and palmitate significantly altered cellular adenosine triphosphate levels (Supplementary Figure 6A) , suggesting that autophagy-deficient cells were not under strong metabolic stress or were unable to efficiently uptake and utilize these nutrients. To ensure nutrient access, the glucose transporter Glut1 was expressed to enhance and maintain glucose uptake even after removal of IL3 (Zhao et al., 2007) . Although Glut1 expression itself did not affect cell death of Atg3-deleted cells, provision of both methyl-pyruvate and oleate and palmitate modestly increased survival of IL3 in both control and 4OHT-treated Glut1-expressing cells ( Figure 4f ). The inability to fully rescue survival suggested a lack of metabolic stress; similarly, the metabolic stress protein phospho-AMP kinase, its downstream target phospho-acetyl-CoA carboxylase, as well as phospho-S6 were unchanged following Atg3 deletion (Supplementary Figure S6B , C). Together, these data suggest that autophagy-derived nutrients are essential in response to direct metabolic stress, but not in the initial days after growth signal deprivation.
Disruption of autophagy leads to induction of pro-apoptotic proteins and p53 activation
In addition to metabolism, autophagy has been implicated in the homeostasis of many pathways and organelles, including the mitochondria and endoplasmic reticulum (Bernales et al., 2006; Hoyer-Hansen and Jaattela, 2007; Kim et al., 2007) . Acute disruption of autophagy led to a small increase in induction of the endoplasmic reticulum stress marker Chop, though this was modest compared with treatment with the endoplasmic reticulum-stress-inducing compound Tunicamycin, and Atg3 deletion led to no increase in the markers BiP or Calnexin (Figure 5a ). Autophagy disruption may also lead to mitochondrial dysfunction and reactive oxygen species stress (Mathew et al., 2009) to activate the p53 pathway (Karawajew et al., 2005; Liu et al., 2008; Niizuma et al., 2009) . Indeed, p53 was strongly phosphorylated on serine 18 (equivalent of human S15), and total p53 protein accumulated after Atg3 deletion (Figure 5b ). In addition to induction of Puma (Figure 3c ), the p53 target gene p21 was induced after Atg3 deletion. Interestingly, gH2A.X, a marker of DNA double-strand breaks that may be upstream of p53 activation (Kurz and Lees-Miller, 2004) , was also increased by disruption of autophagy, particularly after grown factor withdrawal. Although appearance of gH2A.X suggested DNA damage, it was unclear why this followed p53 phosphorylation and induction of the cell-cycle arrest protein p21 (Figure 5b ). Temporal differences in detection of gH2A.X and markers of the DNA damage response may account for this discrepancy, but gH2A.X may also be induced independent of DNA damage. Consistent with this latter possibility, IL3 withdrawal of the IL3-dependent cell line FL5.12 cells led to the accumulation of gH2A.X but not p21 (Figure 5c ), indicating that gH2A.X may be a general marker of cell stress or apoptosis. These data suggest that disruption of autophagy in A3C cells may cause growth arrest and eventual death through p53 phosphorylation, activation and induction of pro-apoptotic target genes including Puma.
Autophagy is critical to inhibit p53 in p185 BCR-Abl-transformed A3C cells Oncogenic kinases such as BCR-Abl mimic growth factor signals and are the targets of selective kinase inhibitors in cancer therapy (Kamitsuji et al., 2008; Bellodi et al., 2009) . To examine the role of autophagy in cells expressing an oncogenic kinase, p185 BCR-Abl was stably expressed in A3C cells alone or with Glut1 (Supplementary Figure S7A, B) . Efficient Atg3 excision was observed in the BCR-Abl and BCR-Abl/Glut1-expressing cells (Supplementary Figure S7C) and autophagy was suppressed, indicated by accumulation of p62 (Supplementary Figure S7C) and decreased LC3-II (Supplementary Figure S7D) . Interestingly, BCR-Ablexpressing cells had less basal LC3-II than control cells (Supplementary Figure S7D) , suggesting lower levels of basal autophagy. Consistent with a survival role for autophagy in BCR-Abl-expressing cells, imatinib treatment blocked BCR-Abl kinase activity and signaling (Supplementary Figure S7E) (Kharas and Fruman, 2005; Modi et al., 2007) , and led to cell death that was augmented by Atg3 deletion (Figure 6a) .
Given the enhancement of death with simultaneous disruption of autophagy and BCR-Abl inhibition, we next sought to determine how basal autophagy impacted cell growth and survival in BCR-Abl-expressing cells. BCR-Abl-expressing cells were capable of growth independent of IL3 (Figures 6b and c) , but Atg3 excision in either the presence or absence of IL3 led to cell cycle arrest and rapid cell death similar to control cells (Figures 6b and c) . Notably, Glut1 expression did not confer protection from this death ( Supplementary  Figures S8A, B) , and there was no activation of the downstream phospho-AMP kinase target phospho-phospho-acetyl-CoA carboxylase (Supplementary Figure 6C) , suggesting cell death was not likely due to metabolic stress. Rather, Atg3 deletion led to greater p53 phosphorylation and accumulation, as well as increased induction autophagy or potential Atg3-specific effects. We therefore chemically inhibited autophagy by culturing A3C control and BCR-Abl-expressing cells in either chloroquine, which can inhibit the final lysosomal degradation step of autophagic digestion (Solomon and Lee, 2009 ), or 3-methyladenine, which inhibits a PI3K upstream of autophaghy (Seglen and Gordon, 1982) . Chloroquine had a minor effect on growth and survival of control A3C cells cultured in IL3, but strongly inhibited both growth and survival of BCR-Abl-expressing cells (Figures 7a and b) . Likewise, 3-methyladenine treatment inhibited cell accumulation and led to death in control and BCR-Abl-expressing cells (Figures 7c and d) , though BCR-Abl-expressing cells were somewhat more resistant to 3-methyladenine. Together, these data support the notion that BCR-Abl-expressing A3C cells are reliant on autophagy rather than an Atg3-specific function.
Cell cycle arrest and apoptosis upon Atg3 deletion may have been due to activation of p53. To examine the importance of the p53 pathway in the death of Atg3-deficient Bcr-Abl-expressing cells, cells were transduced to stably express a p53 small hairpin RNA interference (Mason et al., 2010) . This partial p53 knockdown reduced induction of both p21 and Puma in 4OHT-treated cells (Figure 8a , quantitation for p21, Puma and gH2A.X provided), and allowed continued cell accumulation (Figure 8b ) and a modest reduction in death (Figure 8c ) even after Atg3 deletion. The tumor suppressor p53, therefore, is essential for cell cycle arrest and may contribute to apoptosis in BCR-Abl-expressing cells following deletion of Atg3.
Inhibition of autophagy prevents formation of BCR-Abl
The sensitivity of BCR-Abl-expressing cells to disruption of autophagy suggested that autophagy may have an important role to support BCR-Abl-driven leukemia in vivo. To directly examine the role of autophagy in leukemia, control or BCR-Abl-expressing A3C cells were intravenously injected into immuno-deficient recipients. Mice were then control-treated or were treated with tamoxifen for 3 days to activate Cre-ER and promote in vivo deletion of Atg3 (Figure 9a ). At no point did animals that received control A3C cells develop disease. In contrast, mice that received BCRAbl-expressing A3C cells and were control-treated, all developed leukemias (Figure 9a ) that were characterized by splenomegaly (Figures 9b) and disruption of splenic architecture (Figure 9c) . None of the animals that received BCR-Abl cells and were treated with tamoxifen to delete Atg3, however, showed signs of leukemia or significant alteration of spleen size or architecture in this period. In a separate experiment, mice injected with BCR-Abl-expressing cells and then treated with tamoxifen immediately or 2 weeks after injection did not develop enlarged spleens compared with control-treated mice (Figure 9d ), suggesting that disruption of autophagy can affect the course of a more established cancer. Thus, acute deletion of Atg3 and disruption of autophagy was sufficient to prevent progression of BCR-Abl-dependent leukemia in vivo.
Discussion
Autophagy can have a critical role to promote survival, so we generated a growth factor-dependent cell model in which the autophagy-essential gene Atg3 could be inducibly excised by activation of Cre-ER. This acute genetic approach to disrupt autophagy avoided nonspecific or partial effects from pharmacologic or RNA interference-mediated inhibition of autophagy as well as developmental compensation from germline knockouts. Cells lacking Atg3 underwent more rapid cell death, had reduced levels of lipid metabolism, and showed a mild endoplasmic reticulum stress and robust activation of the p53 pathway that was essential for efficient p21 and Puma induction as well as cell cycle arrest. Importantly, BCR-Abl-expressing cells relied on autophagy, as Atg3 excision or pharmacologic inhibition of autophagy led to cell death and prevented BCR-Abl-dependent leukemia. The acute genetic disruption of autophagy demonstrates the critical importance of this pathway in control of cell stress and survival.
Deletion of Atg3 appears to have strongly suppressed autophagy. Atg3 is a highly conserved E2-like enzyme responsible for the lipidation of several downstream targets critical in autophagy, including LC3, GABAR-AP and Gate-16 (Weidberg et al., 2010) , which each showed decreased processing upon Atg3 excision. Protection of p62 and decreased GFP-LC3 punctae formation in Atg3-deficient cells further suggested autophagic disruption. Although complete blockade of autophagy was not observed in the entire cell population at timepoints considered, this may have been because of incomplete deletion of Atg3 or degradation of Atg3 protein after gene excision. Additionally, although Atg3 targets are important in autophagy, GABARAP and Gate-16 have been shown to be critical in multiple membrane trafficking events unrelated to autophagy Sagiv et al., 2000; Lainez et al., 2010) . Altered lipidation of these proteins may, therefore, also affect other cellular processes independent of autophagy. Similar findings using pharmacologic inhibitors 3-MA and chloroquine, however, suggest that autophagy itself was essential to growth and survival. It remains unclear why autophagy was necessary for cell survival. Although growth factors are essential to promote glucose uptake and glycolysis, autophagy can derive metabolic precursors from lysosomal digestion of organelles and other materials for metabolism in the absence of growth factor input (Lum et al., 2005a; Altman et al., 2009; Singh et al., 2009) . Here, we show that autophagy was essential to increase mitochondrial oxidation of long-chain fatty acids in growth factordeprived cells. This autophagy-dependent contribution to cell metabolism was critical when glycolysis was directly disrupted, but did not appear essential in growth factor withdrawal. This finding contrasts with that of Lum et al., in which chronically growth factordeprived cells deficient in apoptosis relied on autophagy to support basal cell metabolism (Lum et al., 2005a) . It is likely that in apoptosis-competent cells, autophagy provides nutrients, yet is essential to alleviate other acute cell stresses. Autophagy can also contribute to apoptosis by promoting induction of the pro-apoptotic protein Bim Kiyono et al., 2009) . In these cases, RNA interference partially suppressed autophagy rather than the more complete blockade caused by Atg3 deletion. Autophagy may affect cell stress and apoptotic pathways through multiple means, therefore, that depend in part on the overall levels of autophagic flux.
Autophagy can degrade damaged organelles such as mitochondria (Colell et al., 2007) and endoplasmic reticulum (Bernales et al., 2006) , mitigate reactive oxygen species stress, degrade protein aggregates and prevent DNA damage Pankiv et al., 2007; Mathew et al., 2009) . Two distinct stress pathways were induced downstream of autophagy disruption that may contribute to the cellular need for autophagy. We observed an apparent mild endoplasmic reticulum stress that was characterized by a modest induction of the pro-apoptotic transcription factor Chop/GADD153. The endoplasmic reticulum can be regulated by autophagy (Bernales et al., 2006; HoyerHansen and Jaattela, 2007) , and Chop is important in the transcription of the pro-apoptotic proteins Bim and Puma (Ishihara et al., 2007; Puthalakath et al., 2007; Altman et al., 2009) , which were also transcribed downstream of autophagy disruption. Previously we had shown using RNA interference that partial inhibition of autophagy led to increased Chop induction relative to cells with normal levels of autophagy . Partial changes in levels of autophagy may, therefore, have distinct effects of cellular outcome. Alternatively, cell-type-specific effects of autophagy-deficiency may also lead to distinct effects on Chop.
Loss of autophagy led to a robust stress response that included activation of p53 and accumulation of the double-strand DNA break marker gH2A.X (Kurz and Lees-Miller, 2004) . p53 was strongly phosphorylated and accumulated after autophagy disruption, and we observed induction of p53 targets including the cell cycle inhibitor p21 and the pro-apoptotic Bcl-2 family protein Puma. Although p53 can be upstream of autophagy (Feng et al., 2005; Crighton et al., 2006; Wan et al., 2008) , this induction of the p53 pathway downstream of autophagy disruption may reflect a novel mechanism by which autophagy can suppress cell stress. Indeed, p53 was critical in cell cycle arrest and death after Atg3 deletion. gH2A.X accumulation suggested DNA damage, but this marker was also induced upon growth factor withdrawal in the absence of p21 accumulation. It is not clear, therefore, if the discrepancy between gH2A.X and phospho-p53, and p21 accumulation is due to a low level of DNA damage or an alternate cell stress pathway to activate p53. Similar findings of cell stress upon inhibition of autophagy have been reported in other systems and may be due to reactive oxygen species or protein aggregates Mathew et al., 2009) . Although the partial effects on cell cycle and death by p53 RNA interference may be because of remaining p53 protein or through an alternate pathway, these data indicate that p53 contributes to cell fate when autophagy is suppressed.
There has been significant interest in determining if manipulation of autophagy may provide alternative approaches to cancer therapy. Indeed, cancer cells that resist apoptosis have been shown to require autophagy to survive nutrient stress (Degenhardt et al., 2006; Karantza-Wadsworth et al., 2007) and clear protein aggregates (Pankiv et al., 2007; Mathew et al., 2009) . Importantly, we found that, although autophagy can serve as a source of nutrients, this did not appear to represent the critical function for autophagy to support cell viability in acute settings when growth signals were suppressed or in cells with active BCR-Abl. Rather, a key function of autophagy was to alleviate cell stress and p53 activation. Autophagy is constitutively activated at low levels in p185 BCR-Abl-expressing cells and is cytoprotective both under normal conditions and after treatment with the kinase inhibitor imatinib. Given the reliance of BCR-Abl-expressing cells on autophagy and that autophagy can be activated by many cancer treatments (Carew et al., 2007; Kamitsuji et al., 2008; Bellodi et al., 2009; Lomonaco et al., 2009; Ren et al., 2010) , cancer cells may have a 'non-oncogene addiction' to autophagy that could be exploited even in nutrient replete conditions (Luo et al., 2009) . Consistent with this notion, the autophagy and lysosome-inhibiting drug chloroquine has shown efficacy in enhancing cell death following treatment with other chemotherapeutics (Amaravadi et al., 2007; Kamitsuji et al., 2008; Solomon and Lee, 2009 ). It will be important in future studies to further examine and understand how autophagy impacts cell stress and the p53 pathway in cancer cells that express oncogenic kinases so that inhibition of autophagy may be effectively combined with targeted therapies to treat cancer.
